InvestorsHub Logo
Followers 22
Posts 4308
Boards Moderated 0
Alias Born 04/16/2013

Re: None

Thursday, 12/28/2023 10:30:47 PM

Thursday, December 28, 2023 10:30:47 PM

Post# of 56668
A great comparison to QSEP is biotech.

Biotech companies do advanced research studies for their drugs and then apply for FDA approval.

If during the trial phases they get results that are less than expected, the stocks tank, but the company does generally not go out of business. They regroup, redirect and go back to the trial phase. A lot like QSEP makes design and engineering changes before going back out into the field and trying again.

If the biotech company gets good results on ensuing trials, their stock skyrockets. If QSEP gets a contract it would instantly validate the technology and the stock would skyrocket on speculation, simply because of the potential revenue it could generate. Very similar to a biotech company.

Having bad trials or tests are not the end of the line. Biotech cos have proven that. QSEP has indeed proven that over the many years it has continued to survive, much to the chagrin of the bears.

QSEP might just knock the bears out if they get a contract. Wouldn’t that be something ;)

Long.